Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03222037
Other study ID # CR-5968
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date June 27, 2017
Est. completion date August 4, 2017

Study information

Verified date August 2019
Source Johnson & Johnson Vision Care, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a bilateral, non-dispensing, randomized, cross-over, single-masked study. There are a total of 3 visits where all study endpoints will be measured in all subjects at baseline with habitual lenses and under the two testing treatments sequentially in separate visits based on the randomization scheme


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date August 4, 2017
Est. primary completion date August 4, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

Potential subjects must satisfy all of the following criteria to be enrolled in the study:

1. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form

2. Appear able and willing to adhere to the instructions set forth in this clinical protocol

3. Between 18 and 35 (inclusive) years of age at the time of screening

4. The subject must be habitual contact lens wearers (defined as minimum 6 hours per day, 5 days a week over the last month)

5. The subject must meet all of the following three criteria:

1. The eyes' spherical equivalent distance refraction must be in the range of -1.00 to -9.00 D (inclusive)

2. The eyes' refractive cylinder must be less than or equal to -0.75 DC

3. Each eye must have best corrected visual acuity of 20/25 or better.

6. The subject must have normal eyes (i.e., no ocular medications or infections of any type)

Exclusion Criteria:

Potential subjects who meet any of the following criteria will be excluded from participating in the study:

1. Currently pregnant or lactating

2. Any systemic disease (e.g., Sjögren's Syndrome), allergies, infectious disease (e.g., hepatitis, tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g. rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with contact lens wear and/or participation in the study

3. Use of systemic medications (e.g., chronic steroid use) that are known to interfere with contact lens wear or may impact the functioning of the tear film (e.g., Isotretinoin)

4. Any ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or corneal distortion

5. Any current use of ocular medication

6. Any previous, or planned (during the course of the study) ocular surgery (e.g., radial keratotomy, PRK, LASIK, etc.)

7. Any Grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the Efron scale

8. Any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that would contraindicate contact lens wear

9. Any known hypersensitivity or allergic reaction to contact lens care products.

10. Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment

11. Employee of clinical site (e.g., Investigator, Coordinator, Technician)

12. Current wearers of Acuvue Oasys 1-Day brand contact lenses

Study Design


Related Conditions & MeSH terms


Intervention

Device:
senofilcon A
Acuvue Oasys 1-Day
Control
Trial Frame with best spherocylindrical refraction (SCR)

Locations

Country Name City State
United States VRC East Jacksonville Florida

Sponsors (1)

Lead Sponsor Collaborator
Johnson & Johnson Vision Care, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Acuity (logMAR) Visual Acuity was collected electronically under two conditions (high luminance low contrast and low luminance high contrast) in both eyes 15- minutes post study article administration. The average visual acuity for each lens type and condition was reported. 15 Minutes post Treatment Administration
Secondary Area Under Contrast Sensitivity Function Curve Contrast sensitivity was assessed in both eyes at 1.5, 3.0, 6.0, 12.5 and 18.0 cycles per degrees (cpd) using AST Sentio vision Testing System. During testing 25 triplets of test letters were displayed on a large stationary monitor (118 CM), the operator recorded the patients responses using the remote (Android Tablet). After a testing session had been completed the software calculated the Area under the log contrast sensitivity function from 1.5 cpd to 18 cpd. 15 minutes post treatment administration
See also
  Status Clinical Trial Phase
Completed NCT06019806 - Effects of Forward Head Posture Correction on Visual Acuity in Low Level Visually Impaired University Students N/A
Completed NCT04567186 - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Hyperopic Population N/A
Completed NCT02568254 - Evaluation of Three Daily Disposable Contact Lenses N/A
Completed NCT01951703 - Senofilcon A Investigational Manufacturing Process N/A
Terminated NCT00637468 - EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye Phase 3
Recruiting NCT04632901 - A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
Active, not recruiting NCT03747601 - Temporal Interference Brain Stimulation N/A
Completed NCT06131476 - Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop Phase 1
Recruiting NCT05414565 - Post-Market Study of Alcon Intraocular Lenses
Completed NCT05056870 - Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats N/A
Completed NCT04615507 - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2 N/A
Completed NCT05099380 - Validation of Senofilcon A With New UV / HEV Filter N/A
Completed NCT03713281 - Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population
Completed NCT05582304 - Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study N/A
Completed NCT03742271 - Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population N/A
Completed NCT04995055 - Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual Function N/A
Completed NCT05554640 - Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses N/A
Completed NCT01926704 - MTF Image Modifications N/A
Completed NCT04649606 - Dynamic Characterisation of Meibomian Gland Structure
Completed NCT05101252 - Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product N/A